89 related articles for article (PubMed ID: 8624237)
21. The effect of ipriflavone treatment on osteoporosis induced by immobilization.
Földes I; Rapcsák M; Szöör A; Gyarmati J; Szilágyi T
Acta Morphol Hung; 1988; 36(1-2):79-93. PubMed ID: 3149863
[TBL] [Abstract][Full Text] [Related]
22. Minor pyrano-isoflavones from Eriosema kraussianum: activity-, structure-, and chemical reaction studies.
Drewes SE; Horn MM; Khan F; Munro OQ; Dhlamini JT; Rakuambo C; Meyer JJ
Phytochemistry; 2004 Jul; 65(13):1955-61. PubMed ID: 15280002
[TBL] [Abstract][Full Text] [Related]
23. [Metabolism of ipriflavone].
Ferenc L; István S
Acta Pharm Hung; 1995 Nov; 65(6):215-8. PubMed ID: 8742628
[TBL] [Abstract][Full Text] [Related]
24. Ipriflavone modulates IGF-I but is unable to restore bone in rats.
Deyhim F; Smith BJ; Soung DY; Juma S; Devareddy L; Arjmandi BH
Phytother Res; 2005 Feb; 19(2):116-20. PubMed ID: 15852487
[TBL] [Abstract][Full Text] [Related]
25. Invariom structure refinement, electrostatic potential and toxicity of 4-O-methylalpinumisoflavone, O,O-dimethylalpinumisoflavone and 5-O-methyl-4-O-(3-methylbut-2-en-1-yl)alpinumisoflavone.
Kingsford-Adaboh R; Dittrich B; Hübschle CB; Gbewonyo WS; Okamoto H; Kimura M; Ishida H
Acta Crystallogr B; 2006 Oct; 62(Pt 5):843-9. PubMed ID: 16983165
[TBL] [Abstract][Full Text] [Related]
26. [Experience with ipriflavone therapy in postmenopausal osteoporosis].
Szántó F
Orv Hetil; 1997 Nov; 138(44):2801-3. PubMed ID: 9411349
[TBL] [Abstract][Full Text] [Related]
27. Ipriflavone down-regulates endothelin receptor levels during differentiation of rat calvarial osteoblast-like cells.
Hagiwara H; Naruse M; Adachi C; Inoue A; Hiruma Y; Otsuka E; Naruse K; Demura H; Hirose S
J Biochem; 1999 Jul; 126(1):168-73. PubMed ID: 10393335
[TBL] [Abstract][Full Text] [Related]
28. One-step synthesis of diarylpyrazolo[3,4-b]pyridines from isoflavones.
Zhang ZT; Liang Y; Ma YQ; Xue D; Yang JL
J Comb Chem; 2010 Jul; 12(4):600-3. PubMed ID: 20524639
[TBL] [Abstract][Full Text] [Related]
29. One-step synthesis of 5,6-diaryl pyridine-2(1H)-thiones from isoflavones.
Wang J; Zhang Z; Wang W; Liu F
Org Biomol Chem; 2013 Mar; 11(12):2034-8. PubMed ID: 23396324
[TBL] [Abstract][Full Text] [Related]
30. Comparative Structural Characterization of Spiral Dextrin Inclusion Complexes with Vitamin E or Soy Isoflavone.
Wang PP; Qin XS; Yang QY; Luo ZG; Xiao ZG; Peng XC
J Agric Food Chem; 2017 Oct; 65(39):8744-8753. PubMed ID: 28910527
[TBL] [Abstract][Full Text] [Related]
31. Low hygroscopic spray-dried powders with trans-glycosylated food additives enhance the solubility and oral bioavailability of ipriflavone.
Fujimori M; Kadota K; Kato K; Seto Y; Onoue S; Sato H; Ueda H; Tozuka Y
Food Chem; 2016 Jan; 190():1050-1055. PubMed ID: 26213075
[TBL] [Abstract][Full Text] [Related]
32. Prevention of retinoic acid-induced osteoporosis in mice by isoflavone-enriched soy protein.
Yang J; Wu N; Peng J; Yang X; Guo J; Yin S; Wang J
J Sci Food Agric; 2016 Jan; 96(1):331-8. PubMed ID: 25645024
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of ipriflavone in preventing adverse effects of leuprolide.
Somekawa Y; Chiguchi M; Ishibashi T; Wakana K; Aso T
J Clin Endocrinol Metab; 2001 Jul; 86(7):3202-6. PubMed ID: 11443189
[TBL] [Abstract][Full Text] [Related]
34. Hydrogen bonding and pi-pi stacking in methylaminium 4',7-dihydroxyisoflavone-3'-sulfonate dihydrate and hexaaquairon(II) bis(4',7-diethoxyisoflavone-3'-sulfonate) tetrahydrate.
Zhang ZT; Cheng XL; He Y
Acta Crystallogr C; 2006 Oct; 62(Pt 10):m484-7. PubMed ID: 17008736
[TBL] [Abstract][Full Text] [Related]
35. Structural characterization of some N-phenyl-4-oxo-4H-2-chromone carboxamides.
Gomes LR; Low JN; Cagide F; Gaspar A; Reis J; Borges F
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2013 Jun; 69(Pt 3):294-309. PubMed ID: 23719474
[TBL] [Abstract][Full Text] [Related]
36. 5-Acetyl-2-amino-6-methyl-4-(1-naphthyl)-4H-pyran-3-carbonitrile, methyl 6-amino-5-cyano-2-methyl-4-(1-naphthyl)-4H-pyran-3-carboxylate and tert-butyl 6-amino-5-cyano-2-methyl-4-(1-naphthyl)-4H-pyran-3-carboxylate.
Nesterova SV; Wiedenfeld DJ; Nesterov VN
Acta Crystallogr C; 2004 Aug; 60(Pt 8):o559-63. PubMed ID: 15295187
[No Abstract] [Full Text] [Related]
37. Total synthesis of the pyranoisoflavone kraussianone 1 and related isoflavones.
Selepe MA; Drewes SE; van Heerden FR
J Nat Prod; 2010 Oct; 73(10):1680-5. PubMed ID: 20718472
[TBL] [Abstract][Full Text] [Related]
38. Lack of any estrogenic effect of ipriflavone in postmenopausal women.
Melis GB; Paoletti AM; Cagnacci A; Bufalino L; Spinetti A; Gambacciani M; Fioretti P
J Endocrinol Invest; 1992 Nov; 15(10):755-61. PubMed ID: 1491124
[TBL] [Abstract][Full Text] [Related]
39. The characterisation of structural and antioxidant properties of isoflavone metal chelates.
Dowling S; Regan F; Hughes H
J Inorg Biochem; 2010 Oct; 104(10):1091-8. PubMed ID: 20656356
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, crystal structure and photoluminescence of 3-(4-(anthracen-10-yl)phenyl)-benzo[5,6]coumarin.
Zhang H; Yu T; Zhao Y; Fan D; Xia Y; Zhang P; Qiu Y; Chen L
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jan; 75(1):325-9. PubMed ID: 20004142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
